Skip to main content

Table 1 The average prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea between 2012 and 2015

From: Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea

 

Prevalence a

Incidence a

Male

Female

Total

Female-to-Male Ratio

Male

Female

Total

Female-to-Male Ratio

Parkinson’s disease

 Age group (years)

       

  0–19

0.20

0.21

0.20

1.06

0.09

0.11

0.10

1.44

  20–24

1.14

1.09

1.12

0.95

0.36

0.50

0.43

1.43

  25–29

1.82

1.35

1.59

0.76

0.66

0.43

0.55

0.72

  30–34

3.59

3.02

3.31

0.85

1.11

1.09

1.10

1.03

  35–39

7.26

5.50

6.39

0.76*

2.09

1.63

1.87

0.78

  40–44

13.33

10.68

12.03

0.80*

3.65

3.17

3.41

0.88

  45–49

30.37

27.68

29.05

0.91

7.29

7.03

7.16

0.96

  50–54

67.17

65.26

66.22

0.97

15.60

14.87

15.24

0.95

  55–59

136.22

137.60

136.92

1.01

29.64

29.79

29.72

1.01

  60–64

275.18

303.45

289.59

1.10*

59.55

62.35

60.98

1.05

  65–69

554.05

596.42

576.41

1.08*

120.28

118.07

119.13

0.98

  70–74

1017.86

1176.07

1106.37

1.16*

222.20

233.59

228.58

1.05

  75–79

1565.52

1704.63

1649.67

1.09*

335.35

327.22

330.40

0.98

  80-

1721.25

1434.80

1519.63

0.83*

373.14

253.97

289.30

0.68*

  Total

139.58

202.43

171.01

1.45*

30.44

39.49

34.97

1.30*

Age-standardized rates

 WHO 2000–2025

113.10

116.00

114.13

–

24.75

22.97

23.49

–

 US 2000

176.86

177.96

176.21

–

38.57

34.64

35.79

–

Drug-induced parkinsonism

 Age group (years)

  0–19

2.42

1.41

1.94

0.61*

2.30

1.34

1.84

0.60*

  20–24

6.28

5.90

6.10

0.91

5.69

5.43

5.57

0.93

  25–29

7.50

7.18

7.35

0.98

6.89

6.47

6.69

0.96

  30–34

8.03

8.39

8.21

1.05

7.13

7.49

7.31

1.04

  35–39

11.73

11.87

11.80

1.02

10.25

10.45

10.35

1.04

  40–44

14.98

13.84

14.42

0.94

12.62

12.31

12.47

0.98

  45–49

14.96

15.37

15.16

1.02

12.75

13.61

13.18

1.07

  50–54

12.05

15.34

13.68

1.33*

10.64

13.36

11.99

1.31*

  55–59

10.58

15.05

12.82

1.55*

9.56

12.97

11.27

1.51*

  60–64

10.01

13.99

12.04

1.43*

8.71

12.61

10.70

1.49*

  65–69

9.57

14.70

12.26

1.57*

8.56

12.93

10.86

1.55*

  70–74

10.30

18.82

15.06

1.84*

9.36

17.55

13.94

1.90*

  75–79

12.38

19.46

16.65

1.57*

11.40

18.02

15.39

1.58*

  80-

11.18

12.83

12.34

1.19

10.26

11.95

11.45

1.20

Total

9.02

10.53

9.78

1.19*

7.97

9.41

8.69

1.21*

Age-standardized rates

 WHO 2000–2025

7.66

8.24

7.99

–

6.81

7.38

7.13

–

 US 2000

8.44

9.35

8.95

–

7.48

8.37

7.98

–

  1. a Prevalence and incidence are average of those from 2012 to 2015 and reported as per 100,000 persons and per 100,000 person-years, respectively
  2. * P < 0.05
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us